Structure‑based identification of SARS‑CoV‑2 main protease inhibitors from anti‑viral specific chemical libraries : an exhaustive computational screening approach

Show simple item record

dc.contributor.author Bhowmick, Shovonlal
dc.contributor.author Saha, Achintya
dc.contributor.author Osman, Sameh Mohamed
dc.contributor.author Alasmary, Fatmah Ali
dc.contributor.author Almutairi, Tahani Mazyad
dc.contributor.author Islam, Md Ataul
dc.date.accessioned 2022-09-20T04:38:14Z
dc.date.available 2022-09-20T04:38:14Z
dc.date.issued 2021-08
dc.description.abstract Worldwide coronavirus disease 2019 (COVID-19) outbreak is still threatening global health since its outbreak first reported in the late 2019. The causative novel virus has been designated as severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2). Although COVID-19 emergent with significant mortality, there is no availability of definite treatment measures. It is now extremely desirable to identify potential chemical entities against SARS-CoV-2 for the treatment of COVID-19. In the present study, a state-of-art virtual screening protocol was implemented on three anti-viral specific chemical libraries against SARS-CoV-2 main protease ( Mpro). Particularly, viewing the large-scale biological role of Mpro in the viral replication process it has been considered as a prospective anti-viral drug target. Herein, on collected 79,892 compounds, hierarchical multistep docking followed by relative binding free energy estimation has been performed. Thereafter, implying a user-defined XP-dock and MM-GBSA cut-off scores as −8.00 and −45.00 kcal/mol, chemical space has been further reduced. Exhaustive molecular binding interactions analyses and various pharmacokinetics profiles assessment suggested four compounds (ChemDiv_D658-0159, ChemDiv_F431-0433, Enamine_Z3019991843 and Asinex_LAS_51389260) as potent inhibitors/modulators of SARS-CoV-2 Mpro. In-depth protein–ligand interactions stability in the dynamic state has been evaluated by 100 ns molecular dynamics (MD) simulation studies along with MM-GBSA-based binding free energy estimations of entire simulation trajectories that have revealed strong binding affinity of all identified compounds towards Mpro. Hence, all four identified compounds might be considered as promising candidates for future drug development specifically targeting the SARS-CoV-2 Mpro; however, they also need experimental assessment for a better understanding of molecular interaction mechanisms. en_US
dc.description.department Chemical Pathology en_US
dc.description.librarian am2022 en_US
dc.description.sponsorship The Deanship of Scientific Research at King Saud University. en_US
dc.description.uri http://link.springer.com/journal/11030 en_US
dc.identifier.citation Bhowmick, S., Saha, A., Osman, S.M. et al. Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach. Molecular Diversity 25, 1979–1997 (2021). https://doi.org/10.1007/s11030-021-10214-6. en_US
dc.identifier.issn 1381-1991 (print)
dc.identifier.issn 1573-501X (online)
dc.identifier.other 10.1007/s11030-021-10214-6
dc.identifier.uri https://repository.up.ac.za/handle/2263/87224
dc.language.iso en en_US
dc.publisher Springer en_US
dc.rights © Crown 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License. en_US
dc.subject Main protease en_US
dc.subject Molecular docking en_US
dc.subject Virtual screening en_US
dc.subject Molecular dynamics en_US
dc.subject MM-GBSA en_US
dc.subject Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.title Structure‑based identification of SARS‑CoV‑2 main protease inhibitors from anti‑viral specific chemical libraries : an exhaustive computational screening approach en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record